1 Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
2 Department of Human Genetics, KU Leuven, Herestraat 49 Box 602, B-3000, Leuven, Belgium.
3 Cancer Research UK London Research Institute, London, WC2A3LY, UK.
4 Norwich Medical School and Department of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, UK.
5 The Genome Analysis Centre, Norwich, NR4 7UH, UK.
6 Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital, Tampere, FI-33520, Finland.
7 The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, 21287, USA.
8 Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Maryland, 20892, USA.
9 Avoneaux Medical Institute, Oxford, Maryland, 21654, USA.
10 University of Liverpool andHCA Pathology Laboratories, London, WC1E6JA, UK.
11 Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, SW73RP, UK.
12 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB18RN, UK.
13 Uro-oncology Research Group, Cancer ResearchUKCambridge Institute, Cambridge, CB20RE, UK.
14 Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.
15 Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK; and, Sutton, SM2 5PT, UK.
16 Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. david.wedge@manchester.ac.uk.